Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05846516
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-04-18
Brief Title:
A Study to Evaluate ATP150ATP152 VSV-GP154 and Ezabenlimab in Patients With KRAS G12DG12V Mutated PDAC KISIMA-02
Sponsor:
Amal Therapeutics
Organization:
Amal Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-13
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-18
First Submit QC Date:
May 4 2023
Study First Post Date:
2023-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-07
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL